What is Celanese's gross profit margin?

What guidance did Celanese's management provide for the next earnings period?

What were the key takeaways from Celanese’s earnings call?

What is the market's earnings forecast for Celanese next quarter?

What is the revenue and EPS growth rate for Celanese year over year?

What does Celanese do and what are its main business segments?

What is Celanese's latest dividend and current dividend yield?

Did Celanese beat or miss consensus estimates last quarter?

- **Revenue Growth**: Engineered Materials shows sequential improvement, while Acetyl Chain faces overcapacity challenges.
- **Cost Savings**: $20-25 million annual benefit from Lanaken closure, with $5-10 million realized in 2026.
- **Free Cash Flow Target**: $650-750 million for 2026, supported by working capital reductions and lower taxes.
- **EPS Outlook**: 2026 EPS lift of $1-2 driven by volumetric growth in Engineered Materials and cost reductions.
- **Divestiture Progress**: Halfway to $1 billion target, with deals expected in 2026 to reduce debt.

**【CEO Summary】**
- **Revenue Performance**: Engineered Materials (EM) showed sequential improvement in volume and mix, driven by stabilization in key markets like electronics and automotive. Acetyl Chain faced headwinds from overcapacity and pricing pressures, with EBIT down $400 million year-over-year.
- **Strategic Initiatives**: Targeting $1 billion in divestitures by 2027, with a focus on non-core assets. Lanaken closure expected to deliver $20-25 million annual cost savings, with $5-10 million realized in 2026.
- **Growth Outlook**: EM growth prioritized through innovation and customer partnerships, with 2026 EPS lift of $1-2 driven by volumetric growth and cost reductions. Acetyl Chain recovery dependent on supply-demand balance improvements.
- **Balance Sheet Management**: Refinancing debt to reduce near-term maturities, with free cash flow focus on deleveraging. 2026 free cash flow target of $650-750 million, supported by working capital reductions and lower cash taxes.

**【CFO Financial Commentary】**
- **Free Cash Flow**: 2025 free cash flow of $650 million exceeded expectations, driven by $390 million working capital improvement. 2026 target of $650-750 million includes $100 million from further inventory reductions and $50 million from lower interest expenses.
- **Divestiture Progress**: Halfway toward $1 billion target, with deals expected in 2026. Proceeds will be used to reduce debt and support growth initiatives.
- **Leverage Reduction**: Focus on debt paydown through cash generation and asset sales, with a long-term goal of improving credit metrics.

**【Q&A Highlights】**
- **Market Trends**: Acetyl Chain pricing stabilized in China post-Lunar New Year, but overcapacity remains a challenge. EM growth in electronics and automotive offset softness in China automotive market.
- **Cost Management**: Aggressive cost-reduction programs in both segments, with 2026 savings expected to offset higher raw material costs.
- **Turnaround Impact**: Q2 POM turnaround expected to reduce EBIT by $30 million, but second-half recovery anticipated with demand normalization.
- **Divestiture Strategy**: Prioritizing joint ventures and non-core assets, with potential deals in 2026 to accelerate balance sheet deleveraging.

Celanese Corporation (CE) Q4 2025 Earnings Call Transcript

- **2026 EPS Growth Target**: $1 to $2 driven by $0.40-$0.50 cost savings and EM pipeline expansion. 
- **Strategic Closures**: Lanaken plant closure to save $20-$30M annually, signaling operational efficiency focus. 
- **EM Momentum**: TPEs growing 8% YoY, outpacing ETPs, with high-impact programs targeting EV and medical sectors. 
- **China Policy Impact**: Anti-involution may improve acetyls profitability, with early signs of price stabilization. 
- **Debt Management**: Confident in repaying 2026 debt without revolver use, leveraging Micromax sale and free cash flow.

**【CEO Summary Section】**
- **2026 Outlook**: CEO Scott Richardson projects EPS growth of $1 to $2 in 2026, driven by cost savings ($0.40-$0.50) and EM pipeline contributions. 
- **EM Pricing Momentum**: Engineered Materials (EM) pricing improved in Q3, with opportunities in high-impact programs like EV and medical applications. 
- **Operational Flexibility**: Acetyl chain assets are running at full capacity in the U.S., with Europe and China demand driving flexibility. 
- **Strategic Actions**: Closure of Lanaken plant to save $20-$30M annually, and $1B divestiture target by 2027 (Micromax sale nearing completion). 
- **Risk Management**: Anticipates flattish demand but confident in cost control and pipeline growth to offset macro challenges.

**【CFO Financial Commentary】**
- **Free Cash Flow**: 2025 guidance of $700-$800M, with $250M working capital contribution. 2026 expected to match or exceed 2025 levels. 
- **Interest Expense Reduction**: $30-$40M year-over-year decline in 2026. 
- **Impairment Charge**: Q3 goodwill impairment due to stock price decline, not reflecting EM cash flow weakness. 
- **Debt Management**: Confident in repaying $900M 2026 maturities with Micromax proceeds and free cash flow.

**【Q&A Highlights】**
- **Demand Environment**: No accelerated destocking; channel partners managing inventory in North America. 
- **EM Volume Growth**: Thermoplastic elastomers (TPEs) outperforming engineered thermoplastics (ETPs), with TPEs seeing 8% YoY growth. 
- **China Acetyls**: Pricing stabilization in Q3, with potential upside from Anti-involution policy. 
- **Divestiture Strategy**: Focusing on non-core assets (e.g., JVs, specialty chemicals) to enhance portfolio focus. 
- **AI Integration**: Chemille AI tool enhancing customer engagement and grade selection efficiency.

Celanese Corporation (CE) Q3 2025 Earnings Call Transcript

- **Earnings Guidance**: Q3 EPS expected in $1.10-$1.40 range, with $2 EPS achievable through cost actions and demand recovery.
- **Free Cash Flow Focus**: Prioritizing cash generation over volume, with $700-$800 million FCF target on track despite weaker demand.
- **Demand Volatility**: Short-term order visibility (2-4 weeks) due to inventory destocking, with potential U.S. manufacturing repatriation benefits.
- **Acetyl Chain Strategy**: Shifting to high-margin downstream products, with U.S. exports to Asia unaffected by tariffs.
- **Divestiture Progress**: Micromax deal advancing, with other asset sales focused on maximizing profitability.

**【CEO Summary Section】**
- **Revenue Performance**: Q2 revenue was impacted by weaker demand in China automotive and European markets, with sequential volume declines in acetyls and Engineered Materials (EM). The company expects Q3 EPS in the $1.10-$1.40 range, driven by cost reductions and reduced turnaround activity.
- **Cost Optimization**: Targeting $2 EPS through four controllable actions: cost structure improvements, high-impact programs in differentiated markets, price increases in EM, and value capture in the Acetyl Chain. Free cash flow guidance remains $700-$800 million, prioritizing cash generation over volume.
- **Demand Visibility**: Order book visibility is limited to 2-4 weeks, with customers reducing inventories across the supply chain. The company is focused on operational flexibility to capitalize on demand recoveries.

**【CFO Financial Commentary】**
- **Q2 Results**: GAAP net income of $420 million, with Non-GAAP EPS of $1.08, exceeding expectations. Free cash flow of $220 million was driven by strong operating cash flow despite lower volumes.
- **Inventory Management**: Q3 EM segment earnings were negatively impacted by $25 million from inventory destocking, offsetting $10 million benefits from prior quarter production campaigns. Full-year earnings impact from inventory actions is minimal, with minor Q4 headwinds.
- **Liquidity**: revolver extended to 2030, with no reliance on debt markets for $1 billion divestiture proceeds. Debt maturities through 2027 will be funded by free cash flow and asset sales.

**【Q&A Key Highlights】**
- **Demand Trends**: Softness in China automotive and European EM demand, with no significant share loss in tow business. U.S. manufacturing repatriation could benefit acetyls demand, but visibility remains short-term.
- **Acetyl Chain Dynamics**: Margins at unsustainable levels, with focus on downstream products like emulsions. U.S. acetic acid exports to Asia remain virtual through swaps, unaffected by tariffs.
- **Free Cash Flow Execution**: Operating cash flow generation is strong, with working capital actions supporting $700-$800 million FCF target. Inventory reduction initiatives are multiyear, with no material impact on 2025 earnings.
- **Divestiture Progress**: Micromax divestiture process advancing, with bids expected in Q3. Other non-Micromax deals are more complex but progressing with a focus on high-profitability assets.

Celanese Corporation (CE) Q2 2025 Earnings Call Transcript

- **Second-Half Tailwinds**: $100M potential from cost savings, tow recovery, and reduced turnarounds. 
- **Nylon 66 Focus**: High teens EBITDA margins targeted, with capacity rationalization and pricing actions. 
- **Free Cash Flow Confidence**: $700M-$800M 2025 target backed by working capital and CapEx improvements. 
- **China Growth**: EV volumes up 20% YoY, balancing global demand uncertainty. 
- **Tariff Mitigation**: Engineered Materials tariff impact offset by internal cost actions. 


**【CEO Business Overview】**
- **Revenue Growth and Cost Control**: Q1 revenue growth driven by nylon 66 and acetate tow recovery. Second-half tailwinds include $30M from reduced turnaround costs, $40M from cost reduction actions, and $50M from tow dividend and volume improvements. Total potential tailwind: ~$100M. 
- **Nylon 66 Strategy**: Focus on capacity rationalization, pricing actions, and cost streamlining. Business EBITDA margins similar to Engineered Materials at high teens. 
- **Acetate Tow Recovery**: April volumes up 25% YoY, driven by seasonal demand and reduced destocking. 
- **Free Cash Flow Target**: $700M-$800M for 2025, supported by working capital improvements, reduced CapEx, and tax reductions. 
- **China Expansion**: Automotive content growth in China (EV volumes +20% YoY), balanced against global demand uncertainty. 

**【CFO Financial Highlights】**
- **Q1 Financials**: GAAP net income $420M, Non-GAAP EPS $1.08 (vs. $0.95 consensus). 
- **Cash Generation**: $1.2B free cash flow in 2024, with 2025 target of $700M-$800M. 
- **Leverage Reduction**: Divestitures (e.g., Micromax) and self-help actions to reduce leverage to 4x or below. 
- **Tariff Impact**: $30M annualized headwind from tariffs, primarily in Engineered Materials. 

**【Q&A Key Themes】**
- **Demand Sensitivity**: CEO cautious on second-half demand, with inventory reduction plans to mitigate risk. 
- **Nylon 66 Capacity**: Global overcapacity persists, but price actions and cost control aim to stabilize margins. 
- **Oil Price Impact**: Neutral on oil prices, focusing on demand trends in end markets. 
- **Divestiture Progress**: Micromax sale expected to close Q3, with additional portfolio reviews underway. 
- **Acetyl Chain Margins**: Acetic acid/VAM margins under pressure, but downstream diversification (65% non-acid sales) provides stability. 


Celanese (CE)-6 May 25-2025 Q1 Earnings call transcript

- **Cost-Driven Transformation**: $75M+ cost cuts, $100M CapEx reduction, and Board refresh signal intense focus on cash generation and deleveraging.\n- **Divestiture Pipeline**: Potential deals ranging from $75M to $200M+ to accelerate balance sheet repair.\n- **M&amp;M Margin Challenge**: EBITDA improved since acquisition but offset by nylon price declines; $50-100M complexity reduction efforts to reverse margin compression.\n- **China Auto Growth**: 50%+ kg per car penetration target in EVs, with faster project timelines enabling 6-12 month commercialization.\n- **Free Cash Flow Outlook**: 2025 FCF expected to exceed 2024 levels, driven by working capital improvements and lower taxes.\n- **Debt Management**: Proactive refinancing to extend maturities in strong credit markets.\n

**【CEO Opening Remarks】**
- **Cost Actions & Capital Reduction**: Executed $75M+ cost actions and reduced 2025 capital plan to $300-350M (down $100M from 2024 levels).\n- **Leadership Changes**: Hired Todd Elliott for Engineered Materials to simplify operations; added Chris Kuehn and Scott Sutton to Board for financial expertise.\n- **Shareholder Focus**: Committed to cash generation, margin expansion, and deleveraging through asset sales and operational efficiency.\n- **Divestiture Strategy**: Targeting assets outside core Engineered Materials and Acetyls businesses, with potential deals similar in size to the $200M+ Food Ingredients sale.\n- **2025 Outlook**: Free cash flow expected to exceed 2024 levels, driven by working capital improvements, lower taxes, and reduced CapEx.\n
**【Q&A Key Themes】**
- **Divestiture Size & Timing**: CEO indicated potential deals ranging from smaller than $75M to slightly larger than the $200M Food Ingredients sale, with no immediate need for equity raises.\n- **M&amp;M Business Performance**: EBITDA improved since acquisition but faces margin compression in standard nylon grades; $50-100M complexity reduction initiatives underway.\n- **Acetyls Market Dynamics**: Industry operating below cost curve; team leveraging Clear Lake expansion and value chain flexibility to offset contract price declines.\n- **China Auto Growth**: Lightweighting trends driving 50%+ KPB (kg per car) penetration vs. 20% in West, with faster commercialization timelines (6-12 months vs. 24 months).\n- **Debt Management**: CFO emphasized strong debt market access for extending maturities, targeting prudent refinancing to align with cash generation.\n- **Inventory Management**: Channel inventory rebalancing expected to complete in Q1, with demand stability but no material EBITDA impact from inventory reduction.\n- **JV Rules Impact**: China JV dividend timing shifted due to audit requirements, with first payouts expected in Q2.\n- **2025 EBITDA Guidance**: Management focused on $0.25-0.50/Q1 and $1.25-1.50/Q2, with potential upside from margin recovery in Engineered Materials and Acetyls.\n

Actual											2.29	1.3	1.95	2.09	3.46	5.02	4.82	4.91	5.54	4.99	3.94	1.44	2.01	2.17	2.5	2.24	2.08	2.38	2.44	1.45	0.57	1.44	1.34	0.67
Forecast											2.2508	1.0508	1.7144	1.7236	2.9836	4.4633	4.75	5.0735	4.5051	4.556	3.9632	1.6546	1.6382	2.4853	2.2288	2.3095	1.911	2.7231	2.8522	1.2042	0.3832	1.4027	1.2212	0.9129
Surprise	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	+1.74%	+23.72%	+13.74%	+21.26%	+15.97%	+12.47%	+1.47%	-3.22%	+22.97%	+9.53%	-0.59%	-12.97%	+22.70%	-12.69%	+12.17%	-3.01%	+8.84%	-12.60%	-14.45%	+20.41%	+48.75%	+2.66%	+9.73%	-26.61%

Actual	--	--	--	--	--	--	--	--	--	--	1.46B	1.19B	1.41B	1.59B	1.80B	2.20B	2.27B	2.27B	2.54B	2.49B	2.30B	2.35B	2.85B	2.79B	2.72B	2.57B	2.61B	2.65B	2.65B	2.37B	2.39B	2.53B	2.42B	2.20B
Forecast	--	--	--	--	--	--	--	--	--	--	1.54B	1.08B	1.34B	1.41B	1.73B	1.96B	2.14B	2.28B	2.25B	2.38B	2.26B	2.41B	2.86B	2.96B	2.76B	2.59B	2.67B	2.76B	2.70B	2.37B	2.25B	2.49B	2.50B	2.25B
Surprise	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-5.35%	+10.27%	+4.99%	+12.78%	+3.86%	+12.28%	+6.06%	-0.38%	+12.79%	+4.24%	+1.96%	-2.40%	-0.22%	-5.57%	-1.25%	-0.94%	-2.34%	-3.78%	-1.86%	+0.05%	+5.99%	+1.70%	-3.36%	-2.22%

CE

CE fundamentals

CE Q4 2025 Earnings

Earnings Call

You can ask Aime

CE

CE fundamentals

CE Q4 2025 Earnings

Earnings Call

CE Earnings Call Summary for Q4/20259:00 AM on Feb 18, 2026

CE Earnings Call Summary for Q3/20259:00 AM on Nov 7, 2025

CE Earnings Call Summary for Q2/20259:00 AM on Aug 12, 2025

CE Earnings Call Summary for Q1/20259:00 AM on May 6, 2025

CE Earnings Call Summary for Q4/20249:00 AM on Feb 19, 2025

You can ask Aime